Skip to content

Background

Medication errors are recognised as a major patient safety problem. They occur in all stages of the medication management process and have the potential to lead to patient harm, prolonged hospital stays, readmission or even death. Different measures to improve medication safety in hospitals have been taken to reach the World Health Organization’s (WHOs) target of globally reducing avoidable harm related to medications by 50%, by 2022. 

However, despite the introduction of computerised prescriber order entry solutions, electronic medication administration records, bar code medication administration, automated dispensing devices and other clinical decision support systems in some hospitals, medication errors continue to occur. In particular, in intensive cancer units and ambulatory care/one day hospitals where patients received anticancer medication every month they can significantly impact patient care and outcomes.  

Scope of activities

EAHP’s SIG for the Investigation of Medication Errors and Efficiency  in Oncology would on the one hand be looking at determining the prevalence of medication errors , their causes, including the healthcare professionals shortages and the impact of medication errors in healthcare professionals (know as second victims). On the other hand, the members of the SIG would develop recommendations for lowering medication errors in oncology and improving efficiency across Europe.

Call for the expression of interest (closed)

Please find here the call for the expression of interest. SIG candidates sould hold one of the following qualifications:

SIG candidates should:

The SIG will meet at least once per month for 2 hours. SIG members should expect around 2-4 hours of work per month. 

Geographic diversity will be one overarching criterion applied in the selection of the SIG members. To guarantee the smooth functioning of the SIG, its size will not exceed 20 members. 

The SIG is planned to work for 18 months on this tipic. The Terms of Reference and the Working Plan will be defined by the SIG during the kick-off meeting in November.

Application procedure

Expressions of interest from pharmacists meeting the eligibility criteria should be submitted by email to EAHP Managing Director Jennie Degreef at info@eahp.eu . In order to be deemed admissible, applications must provide EAHP with a: 

Closing date

This Call for Expressions of Interest closes on November 20th, 2023 at 11.59 PM CET. EAHP reserves the right to disregard any application sent after that date/time.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.